Two studies found that the use of KIM-1 associated with pro b-type natriuretic peptide (pro-BNP) or beta 2 microglobulin, GFR, and albuminuria in T2DM seems to improve prediction of kidney function decline [67,68]. Here, HAVCR1 is linked to type 2 diabetes mellitus.